EMR vs HUBB: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EMR and HUBB share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EMR and HUBB exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Emerson Electric is a global industrial-technology company focused on automation, helping manufacturers and process industries run their plants more efficiently, safely, and reliably. Over the past several years Emerson has transformed itself from a diversified industrial conglomerate into a more focused automation pure-play, divesting legacy businesses like its commercial and residential climate-technologies unit and acquiring software and measurement assets. Its core products include process control systems, measurement and analytical instruments, valves and actuators, software for plant operations, and test and measurement equipment, much of it sold under brands like DeltaV, Rosemount, Fisher, AspenTech, and NI (National Instruments). Customers span energy, chemicals, life sciences, power, water, food and beverage, and discrete manufacturing. Emerson makes money by selling this hardware and software plus recurring service, software subscriptions, and aftermarket parts, with a meaningful share of revenue tied to keeping installed systems running. The shift toward higher-margin software and recurring revenue, anchored by its majority stake in AspenTech, is central to its strategy. Emerson is headquartered in St. Louis, Missouri.

Full EMR guide

Hubbell Incorporated makes the physical components that connect, protect, and manage electrical power. It runs two segments: Utility Solutions (roughly $3.7 billion of 2025 sales), which supplies grid infrastructure for transmission and distribution, substations, telecom, and gas, and Electrical Solutions (roughly $2.1 billion), which serves industrial, commercial, and increasingly data center customers with wiring, enclosures, connectors, and controls. Total 2025 revenue was about $5.8 billion. The company sells largely into utilities and electrical contractors, giving it exposure to long-cycle infrastructure spending rather than fast-moving consumer demand.

Full HUBB guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• EMR drivers: Automation pure-play transformation; Software and recurring revenue.
• HUBB drivers: Grid modernization and T&D spending; Electrification and data center demand.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Emerson's end markets are cyclical and tied to industrial capital spending, energy and chemical capex, and the global economy, so downturns can slow orders and revenue. For HUBB, hubbell trades at a premium valuation, so any slowdown in utility capital spending, telecom, or data center demand could compress both earnings and the multiple.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick EMR if you believe its drivers more; HUBB if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EMR and HUBB guides.

EMR. Emerson trades at a premium to the average industrial, reflecting its transformation into a higher-margin automation and software business and its anchor stake in AspenTech. The market values the recurring-revenue mix, margin expansion, and strong cash generation, while weighing acquisition and integration risk. Its Dividend King status and steady cash flow underpin a quality-industrial profile.

HUBB. Hubbell raised its full-year 2026 adjusted EPS guidance after a Q1 beat, reflecting confidence in grid and electrical demand. The stock's high-20s trailing multiple prices in continued double-digit earnings growth, leaving limited room for disappointment. The roughly 1.1% dividend yield reflects a long history of steady dividend increases rather than a high-income profile.

Headline figures (approximate, early 2026): EMR shows revenue (ttm) ~$17-18 billion, operating margin ~20%+, expanding, revenue growth Mid-single-digit underlying, plus acquisitions, software and recurring mix Growing share of revenue; HUBB shows revenue (2025 / ttm) ~$5.8B, adjusted eps (2025) ~$15.17, 2026 adjusted eps guidance ~$19.30-$19.85, market cap ~$26B.

EMR and HUBB are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined EMR and HUBB exposure against your real portfolio. It is not an investment adviser.